{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:15:15Z","timestamp":1778699715697,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE21990"],"award-info":[{"award-number":["DE21990"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["DE023433"],"award-info":[{"award-number":["DE023433"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sj\u00f6gren's syndrome (SjS) is a female-dominated autoimmune disease involving lymphocytic infiltration of the exocrine glands. We have previously demonstrated cleavage of the TAM (Tyro3, Axl, Mer) receptor Mer is enhanced in SjS, leading to defective efferocytosis. Mer also plays a role in modulating phagocyte inflammatory response to apoptotic cells. Here we investigated the SjS macrophage response to apoptotic cells (AC). Bone marrow-derived macrophages (BMDMs) from SjS-susceptible (SjS<jats:sup>s<\/jats:sup>) C57BL\/6.NOD-<jats:italic>Aec1Aec2<\/jats:italic> mice and C57BL\/6 (B6) controls were treated with either AC or CpG-oligodeoxynucleotides. RNA was collected from macrophages and bulk sequencing was performed to analyze transcripts. Cytokine expression was confirmed by Bio-plex. RT-qPCR was used to determine toll-like receptor (TLR) 7 and 9 involvement in BMDM inflammatory response to apoptotic cells. SjS<jats:sup>S<\/jats:sup> BMDMs exhibited a distinct transcriptional profile involving upregulation of a broad array of inflammatory genes that were not elevated in B6 BMDMs by AC. Inhibition of TLR 7 and 9 was found to limit the inflammatory response of SjS<jats:sup>S<\/jats:sup> BMDMs to ACs. ACs elicit an inflammatory reaction in SjS<jats:sup>S<\/jats:sup> BMDMs distinct from that observed in B6 BMDMs. This discovery of aberrant macrophage behavior in SjS in conjunction with previously described efferocytosis defects suggests an expanded role for macrophages in SjS, where uncleared dead cells stimulate an inflammatory response through macrophage TLRs recruiting lymphocytes, participating in co-stimulation and establishing an environment conducive to autoimmunity.<\/jats:p>","DOI":"10.1038\/s41598-022-12608-4","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T10:28:11Z","timestamp":1653128891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bone marrow-derived macrophages from a murine model of Sj\u00f6gren's syndrome demonstrate an aberrant, inflammatory response to apoptotic cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Richard","family":"Witas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuong Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"12608_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15\u201325. https:\/\/doi.org\/10.1002\/art.23177 (2008).","journal-title":"Arthritis Rheum."},{"key":"12608_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin, B. et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: A systematic review and meta-analysis. Ann. Rheum. Dis. 74, 1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 118","key":"12608_CR3","first-page":"185","volume":"37","author":"N Marketos","year":"2019","unstructured":"Marketos, N., Cinoku, I., Rapti, A. & Mavragani, C. P. Type I interferon signature in Sj\u00f6gren\u2019s syndrome: Pathophysiological and clinical implications. Clin. Exp. Rheumatol. 37(Suppl 118), 185\u2013191 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"12608_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos, A. et al. Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J. Autoimmun. 63, 47\u201358. https:\/\/doi.org\/10.1016\/j.jaut.2015.07.002 (2015).","journal-title":"J. Autoimmun."},{"key":"12608_CR5","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1038\/s41467-021-23472-7","volume":"12","author":"P Soret","year":"2021","unstructured":"Soret, P. et al. A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome. Nat. Commun. 12, 3523. https:\/\/doi.org\/10.1038\/s41467-021-23472-7 (2021).","journal-title":"Nat. Commun."},{"key":"12608_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0022034513483315","volume":"92","author":"BM Szczerba","year":"2013","unstructured":"Szczerba, B. M. et al. Type I interferon receptor deficiency prevents murine Sjogren\u2019s syndrome. J. Dent. Res. 92, 444\u2013449. https:\/\/doi.org\/10.1177\/0022034513483315 (2013).","journal-title":"J. Dent. Res."},{"key":"12608_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","volume":"60","author":"S Cha","year":"2004","unstructured":"Cha, S. et al. A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60, 552\u2013565. https:\/\/doi.org\/10.1111\/j.0300-9475.2004.01508.x (2004).","journal-title":"Scand. J. Immunol."},{"key":"12608_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard, C. J. et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome. Nat. Genet. 45, 1284\u20131292. https:\/\/doi.org\/10.1038\/ng.2792 (2013).","journal-title":"Nat. Genet."},{"key":"12608_CR9","doi-asserted-by":"publisher","first-page":"4813795","DOI":"10.1155\/2019\/4813795","volume":"2019","author":"R Witas","year":"2019","unstructured":"Witas, R., Peck, A. B., Ambrus, J. L. & Nguyen, C. Q. Sjogren\u2019s syndrome and TAM receptors: A possible contribution to disease onset. J. Immunol. Res. 2019, 4813795. https:\/\/doi.org\/10.1155\/2019\/4813795 (2019).","journal-title":"J. Immunol. Res."},{"key":"12608_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ni.2986","volume":"15","author":"A Zag\u00f3rska","year":"2014","unstructured":"Zag\u00f3rska, A., Trav\u00e9s, P. G., Lew, E. D., Dransfield, I. & Lemke, G. Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 15, 920\u2013928. https:\/\/doi.org\/10.1038\/ni.2986 (2014).","journal-title":"Nat. Immunol."},{"key":"12608_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009076","volume":"5","author":"G Lemke","year":"2013","unstructured":"Lemke, G. Biology of the TAM receptors. Cold Spring Harb. Perspect. Biol. 5, a009076. https:\/\/doi.org\/10.1101\/cshperspect.a009076 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"12608_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","volume":"109","author":"S Sather","year":"2007","unstructured":"Sather, S. et al. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109, 1026\u20131033. https:\/\/doi.org\/10.1182\/blood-2006-05-021634 (2007).","journal-title":"Blood"},{"key":"12608_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.taap.2012.05.024","volume":"263","author":"YJ Lee","year":"2012","unstructured":"Lee, Y. J. et al. Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol. Appl. Pharmacol. 263, 61\u201372. https:\/\/doi.org\/10.1016\/j.taap.2012.05.024 (2012).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"12608_CR14","doi-asserted-by":"publisher","first-page":"9711","DOI":"10.3390\/ijms22189711","volume":"22","author":"R Witas","year":"2021","unstructured":"Witas, R. et al. Defective efferocytosis in a Murine model of Sj\u00f6gren\u2019s syndrome is mediated by dysfunctional mer tyrosine kinase receptor. Int. J. Mol. Sci. 22, 9711. https:\/\/doi.org\/10.3390\/ijms22189711 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"12608_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/intimm\/dxy055","volume":"30","author":"M Kawano","year":"2018","unstructured":"Kawano, M. & Nagata, S. Efferocytosis and autoimmune disease. Int. Immunol. 30, 551\u2013558. https:\/\/doi.org\/10.1093\/intimm\/dxy055 (2018).","journal-title":"Int. Immunol."},{"key":"12608_CR16","doi-asserted-by":"publisher","first-page":"pdb.prot5080","DOI":"10.1101\/pdb.prot5080","volume":"2008","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt, J. & Porse, B. Bone marrow-derived macrophages (BMM): Isolation and applications. CSH Protoc 2008, pdb.prot5080. https:\/\/doi.org\/10.1101\/pdb.prot5080 (2008).","journal-title":"CSH Protoc"},{"key":"12608_CR17","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1182\/blood.V93.7.2282","volume":"93","author":"MG Cifone","year":"1999","unstructured":"Cifone, M. G. et al. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93, 2282\u20132296 (1999).","journal-title":"Blood"},{"key":"12608_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/1043-6618(94)80086-3","volume":"30","author":"G Migliorati","year":"1994","unstructured":"Migliorati, G., Nicoletti, I., Nocentini, G., Pagliacci, M. C. & Riccardi, C. Dexamethasone and interleukins modulate apoptosis of murine thymocytes and peripheral T-lymphocytes. Pharmacol. Res. 30, 43\u201352. https:\/\/doi.org\/10.1016\/1043-6618(94)80086-3 (1994).","journal-title":"Pharmacol. Res."},{"key":"12608_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat. Commun."},{"key":"12608_CR20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.10258","volume":"46","author":"S Cha","year":"2002","unstructured":"Cha, S., Nagashima, H., Brown, V. B., Peck, A. B. & Humphreys-Beher, M. G. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sj\u00f6gren\u2019s syndrome) on a healthy murine background. Arthritis Rheum. 46, 1390\u20131398. https:\/\/doi.org\/10.1002\/art.10258 (2002).","journal-title":"Arthritis Rheum."},{"key":"12608_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein, A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823\u2013835. https:\/\/doi.org\/10.1038\/nri1957 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"12608_CR22","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/labinvest.3700487","volume":"86","author":"SJ Killedar","year":"2006","unstructured":"Killedar, S. J. et al. Early pathogenic events associated with Sj\u00f6gren\u2019s syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab. Investig. 86, 1243\u20131260. https:\/\/doi.org\/10.1038\/labinvest.3700487 (2006).","journal-title":"Lab. Investig."},{"key":"12608_CR23","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar4682","volume":"16","author":"P Vogelsang","year":"2014","unstructured":"Vogelsang, P., Karlsen, M., Brun, J. G., Jonsson, R. & Appel, S. Altered phenotype and Stat1 expression in Toll-like receptor 7\/8 stimulated monocyte-derived dendritic cells from patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Res. Ther. 16, R166. https:\/\/doi.org\/10.1186\/ar4682 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"12608_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/sji.12520","volume":"85","author":"M Karlsen","year":"2017","unstructured":"Karlsen, M. et al. Expression of toll-like receptors in peripheral blood mononuclear cells of patients with primary Sj\u00f6gren\u2019s syndrome. Scand. J. Immunol. 85, 220\u2013226. https:\/\/doi.org\/10.1111\/sji.12520 (2017).","journal-title":"Scand. J. Immunol."},{"key":"12608_CR25","doi-asserted-by":"publisher","first-page":"1246818","DOI":"10.1155\/2018\/1246818","volume":"2018","author":"J Kiripolsky","year":"2018","unstructured":"Kiripolsky, J. & Kramer, J. M. Current and emerging evidence for toll-like receptor activation in Sj\u00f6gren\u2019s syndrome. J. Immunol. Res. 2018, 1246818. https:\/\/doi.org\/10.1155\/2018\/1246818 (2018).","journal-title":"J. Immunol. Res."},{"key":"12608_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.tripleo.2010.01.006","volume":"109","author":"L Zheng","year":"2010","unstructured":"Zheng, L., Zhang, Z., Yu, C. & Yang, C. Expression of Toll-like receptors 7, 8, and 9 in primary Sj\u00f6gren\u2019s syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109, 844\u2013850. https:\/\/doi.org\/10.1016\/j.tripleo.2010.01.006 (2010).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"12608_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/ard.62.4.359","volume":"62","author":"P Willeke","year":"2003","unstructured":"Willeke, P. et al. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 62, 359\u2013362. https:\/\/doi.org\/10.1136\/ard.62.4.359 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"12608_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676010","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. TLR7 signaling drives the development of Sj\u00f6gren\u2019s syndrome. Front. Immunol. 12, 676010. https:\/\/doi.org\/10.3389\/fimmu.2021.676010 (2021).","journal-title":"Front. Immunol."},{"key":"12608_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cei.13242","volume":"196","author":"T Shimizu","year":"2019","unstructured":"Shimizu, T. et al. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sj\u00f6gren\u2019s syndrome patients. Clin. Exp. Immunol. 196, 39\u201351. https:\/\/doi.org\/10.1111\/cei.13242 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"12608_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","volume":"76","author":"NI Maria","year":"2017","unstructured":"Maria, N. I. et al. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 76, 721\u2013730. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209589 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"12608_CR31","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3389\/fimmu.2019.02096","volume":"10","author":"MR Hillen","year":"2019","unstructured":"Hillen, M. R. et al. Plasmacytoid DCs from patients with Sj\u00f6gren\u2019s syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production. Front. Immunol. 10, 2096. https:\/\/doi.org\/10.3389\/fimmu.2019.02096 (2019).","journal-title":"Front. Immunol."},{"key":"12608_CR32","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1189\/jlb.3A0717-311R","volume":"102","author":"J Kiripolsky","year":"2017","unstructured":"Kiripolsky, J., McCabe, L. G., Gaile, D. P. & Kramer, J. M. Myd88 is required for disease development in a primary Sj\u00f6gren\u2019s syndrome mouse model. J. Leukoc. Biol. 102, 1411\u20131420. https:\/\/doi.org\/10.1189\/jlb.3A0717-311R (2017).","journal-title":"J. Leukoc. Biol."},{"key":"12608_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jop.12209","volume":"43","author":"H Shi","year":"2014","unstructured":"Shi, H. et al. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome in NOD\/Ltj mouse. J. Oral Pathol. Med. 43, 785\u2013791. https:\/\/doi.org\/10.1111\/jop.12209 (2014).","journal-title":"J. Oral Pathol. Med."},{"key":"12608_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00888.x","volume":"116","author":"MG Humphreys-Beher","year":"1999","unstructured":"Humphreys-Beher, M. G., Peck, A. B., Dang, H. & Talal, N. The role of apoptosis in the initiation of the autoimmune response in Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 116, 383\u2013387. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00888.x (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"12608_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s10495-008-0261-2","volume":"13","author":"H Nakamura","year":"2008","unstructured":"Nakamura, H. et al. Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sj\u00f6gren\u2019s syndrome. Apoptosis 13, 1322\u20131330. https:\/\/doi.org\/10.1007\/s10495-008-0261-2 (2008).","journal-title":"Apoptosis"},{"key":"12608_CR36","first-page":"675","volume":"16","author":"L Kong","year":"1998","unstructured":"Kong, L. et al. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin. Exp. Rheumatol. 16, 675\u2013681 (1998).","journal-title":"Clin. Exp. Rheumatol."},{"key":"12608_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/clin.1998.4556","volume":"88","author":"L Kong","year":"1998","unstructured":"Kong, L. et al. Bcl-2 family expression in salivary glands from patients with primary Sj\u00f6gren\u2019s syndrome: Involvement of Bax in salivary gland destruction. Clin. Immunol. Immunopathol. 88, 133\u2013141. https:\/\/doi.org\/10.1006\/clin.1998.4556 (1998).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"12608_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cyto.2014.02.009","volume":"67","author":"JM Kramer","year":"2014","unstructured":"Kramer, J. M. Early events in Sj\u00f6gren\u2019s Syndrome pathogenesis: The importance of innate immunity in disease initiation. Cytokine 67, 92\u2013101. https:\/\/doi.org\/10.1016\/j.cyto.2014.02.009 (2014).","journal-title":"Cytokine"},{"key":"12608_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cei.13077","volume":"191","author":"M Ainola","year":"2018","unstructured":"Ainola, M. et al. Activation of plasmacytoid dendritic cells by apoptotic particles\u2014Mechanism for the loss of immunological tolerance in Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 191, 301\u2013310. https:\/\/doi.org\/10.1111\/cei.13077 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"12608_CR40","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/1529-0131(200111)44:11<2642::aid-art444>3.0.co;2-8","volume":"44","author":"X Wu","year":"2001","unstructured":"Wu, X., Molinaro, C., Johnson, N. & Casiano, C. A. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum. 44, 2642\u20132652. https:\/\/doi.org\/10.1002\/1529-0131(200111)44:11%3c2642::aid-art444%3e3.0.co;2-8 (2001).","journal-title":"Arthritis Rheum."},{"key":"12608_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00018-014-1741-x","volume":"72","author":"J Gamrekelashvili","year":"2015","unstructured":"Gamrekelashvili, J., Greten, T. F. & Korangy, F. Immunogenicity of necrotic cell death. Cell Mol. Life Sci. 72, 273\u2013283. https:\/\/doi.org\/10.1007\/s00018-014-1741-x (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"12608_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2012.11.016","volume":"38","author":"A Okuma","year":"2013","unstructured":"Okuma, A. et al. Enhanced apoptosis by disruption of the STAT3-I\u03baB-\u03b6 signaling pathway in epithelial cells induces Sj\u00f6gren\u2019s syndrome-like autoimmune disease. Immunity 38, 450\u2013460. https:\/\/doi.org\/10.1016\/j.immuni.2012.11.016 (2013).","journal-title":"Immunity"},{"key":"12608_CR43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124\u20131136. https:\/\/doi.org\/10.1016\/j.cell.2007.10.034 (2007).","journal-title":"Cell"},{"key":"12608_CR44","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/cei.12377","volume":"177","author":"SR Vartoukian","year":"2014","unstructured":"Vartoukian, S. R. et al. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjogren\u2019s syndrome. Clin. Exp. Immunol. 177, 618\u2013629. https:\/\/doi.org\/10.1111\/cei.12377 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"12608_CR45","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/art.23368","volume":"58","author":"US Deshmukh","year":"2008","unstructured":"Deshmukh, U. S. et al. Inflammatory stimuli accelerate Sj\u00f6gren\u2019s syndrome-like disease in (NZB x NZW)F1 mice. Arthritis Rheum. 58, 1318\u20131323. https:\/\/doi.org\/10.1002\/art.23368 (2008).","journal-title":"Arthritis Rheum."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12608-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:37:39Z","timestamp":1669347459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12608"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12608-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8593"}}